Continuous Ketorolac Infusion Formulation Predicted to Provide Rapid-Onset Pain Relief

by Neumentum Pharmaceuticals | Mar 5, 2020 | In The Media

Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at BIO CEO and Investor Conference in New York

by Neumentum Pharmaceuticals | Feb 8, 2020 | In The Media

Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2020 Biotech Showcase in San Francisco, CA

by Neumentum Pharmaceuticals | Jan 6, 2020 | In The Media

PALO ALTO, Calif., January 6, 2020 – Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2020 Biotech Showcase being held...

Neumentum, Inc. Executive Chairman, Joseph Pergolizzi, Jr., M.D. and Chief Scientific Officer, Robert Raffa, Ph.D. To Present at 2019 Pain Summit in Philadelphia, PA

by Neumentum Pharmaceuticals | Nov 14, 2019 | In The Media

PALO ALTO, Calif., November 14, 2019 – Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Joseph Pergolizzi, Jr., M.D. and Robert Raffa, Ph.D., will both present keynote speeches at the...

Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2019 BIO Investor Forum in San Francisco, CA

by Neumentum Pharmaceuticals | Oct 17, 2019 | In The Media

PALO ALTO, Calif., October 17, 2019 – Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2019 BIO Investor Forum being held October...